Pooja S. Niphade
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Pooja S. Niphade has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Eknath D. Ahire
MET’s Institute of Pharmacy, BKC, Affiliated to Savitribai Phule Pune University, Adgaon Nashik, Maharashtra, India- 422003
1 shared publication - Nilima A. Thombre
MET Institute of Pharmacy
1 shared publication - Sanjay J. Kshirsagar
Department of Pharmaceutics, MET’s Institute of Pharmacy, Affiliated to Savitribai Phule Pune University, BKC, Adgaon, Nashik, MS-India
1 shared publication
Latest Publications
- Open Access
- 31 March 2022
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 19 (1) , 69-80
Formulation Development and Evaluation of Microemulsion Based Lornoxicam Gel
The objective of the existing research was formulation development and preparation of microemulsion loaded emulgel in augmenting the topical delivery of Lornoxicam. Emulsion and gel combined are recognized as Emulgels. Gelling agents Carbopol 940, 974, 980 were used to formulating Lornoxicam emulgel. The drug release from emulgel was determined depending on the different gelling agents. Clove oil for internal phase and Polyethylene glycol 200 was applied as co-surfactant and Tween 20 as permeation enhancer. Prepared emulgels were evaluated for in-vitro and in- vivo anti-inflammatory activity using Albino mice and stability studies. The optimized batch of emulgel gave better results when compared with the marketed Diclofenac sodium gel. 90.42% drug release was detected in 8 hr. Prepared formulation was free from skin irritation and detected with 62.02% inhibition of edema. Correspondingly, prepared formulations were found to be stable. Developed microemulsion increased solubility of drugs, so that less soluble drugs can be applied in the formulation. Carbopol 980 (1.5 %) gave better results for emulgel. Therefore, microemulsion-loaded Lornoxicam Emulgel detected with better analgesic effect.
- 31 March 2022
- Published by Oriental Scientific Publishing Company in Biosciences Biotechnology Research Asia
- Vol. 19 (1) , 69-80
Open AccessFormulation Development and Evaluation of Microemulsion Based Lornoxicam Gel
The objective of the existing research was formulation development and preparation of microemulsion loaded emulgel in augmenting the topical delivery of Lornoxicam. Emulsion and gel combined are recognized as Emulgels. Gelling agents Carbopol 940, 974, 980 were used to formulating Lornoxicam emulgel. The drug release from emulgel was determined depending on the different gelling agents. Clove oil for internal phase and Polyethylene glycol 200 was applied as co-surfactant and Tween 20 as permeation enhancer. Prepared emulgels were evaluated for in-vitro and in- vivo anti-inflammatory activity using Albino mice and stability studies. The optimized batch of emulgel gave better results when compared with the marketed Diclofenac sodium gel. 90.42% drug release was detected in 8 hr. Prepared formulation was free from skin irritation and detected with 62.02% inhibition of edema. Correspondingly, prepared formulations were found to be stable. Developed microemulsion increased solubility of drugs, so that less soluble drugs can be applied in the formulation. Carbopol 980 (1.5 %) gave better results for emulgel. Therefore, microemulsion-loaded Lornoxicam Emulgel detected with better analgesic effect.